HUMAN PAPILLOMAVIRUS VACCINATION: PAST, PRESENT AND FUTURE

dc.contributor.author	Aimagambetova, Gulzhanat
dc.contributor.author	Azizan, Azliyati
dc.date.accessioned	2022-11-23T10:22:49Z
dc.date.available	2022-11-23T10:22:49Z
dc.date.issued	2022-08-26
dc.identifier.citation	Aimagambetova, G., & Azizan, A. (2022). Human Papillomavirus Vaccination: Past, Present and Future. Vaccines, 10(9), 1398. https://doi.org/10.3390/vaccines10091398	en_US
dc.identifier.uri	http://nur.nu.edu.kz/handle/123456789/6822
dc.description.abstract	The link between human papillomavirus (HPV) infection and different diseases has been well-established since more than four decades ago [1,2]. Moreover, high-risk HPV types were confirmed as causative agents for a variety of malignant conditions, including oropharyngeal, anogenital, and cervical cancers	en_US
dc.language.iso	en	en_US
dc.publisher	Vaccines	en_US
dc.rights	Attribution-NonCommercial-ShareAlike 3.0 United States	*
dc.rights.uri	http://creativecommons.org/licenses/by-nc-sa/3.0/us/	*
dc.subject	human papillomavirus	en_US
dc.subject	causative agents	en_US
dc.subject	oropharyngeal	en_US
dc.subject	anogenital	en_US
dc.subject	cervical cancers	en_US
dc.title	HUMAN PAPILLOMAVIRUS VACCINATION: PAST, PRESENT AND FUTURE	en_US
dc.type	Article	en_US
workflow.import.source	science